Janney Montgomery Scott’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.8M | Sell |
|
|||||
|
2025
Q2 | $1.72M | Buy |
|
|||||
|
2025
Q1 | $1.42M | Sell |
|
|||||
|
2024
Q4 | $2.4M | Buy |
|
|||||
|
2024
Q3 | $1.89M | Sell |
|
|||||
|
2024
Q2 | $2.31M | Buy |
|
|||||
|
2024
Q1 | $1.23M | Buy |
|
|||||
|
2023
Q4 | $1.14M | Buy |
|
|||||
|
2023
Q3 | $518K | Buy |
|
|||||
|
2023
Q2 | $402K | Sell |
|
|||||
|
2023
Q1 | $4.91M | Buy |
|
|||||
|
2022
Q4 | $5.38M | Buy |
|
|||||
|
2022
Q3 | $413K | Buy |
|
|||||
|
2022
Q2 | $215K | Sell |
|
|||||
|
2022
Q1 | $307K | Sell |
|
|||||
|
2021
Q4 | $293K | Sell |
|
|||||
|
2021
Q3 | $1.51M | Buy |
|
|||||
|
2021
Q2 | $1.46M | Sell |
|
|||||
|
2021
Q1 | $1.73M | Buy |
|
|||||
|
2020
Q4 | $516K | Sell |
|
|||||
|
2020
Q3 | $1.22M | Buy |
|
|||||
|
2020
Q2 | $1.45M | Buy |
|
|||||
|
2020
Q1 | $1.01M | Buy |
|
|||||
|
2019
Q4 | $1.13M | Sell |
|
|||||
|
2019
Q3 | $1.01M | Buy |
|
|||||
|
2019
Q2 | $917K | Buy |
|
|||||
|
2019
Q1 | $821K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $452K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $353K | Sell |
|
|||||
|
2015
Q4 | $567K | Hold |
|
|||||
|
2015
Q3 | $399K | Buy |
|
|||||
|
2015
Q2 | $450K | Buy |
|
|||||
|
2015
Q1 | $294K | Buy |
|